These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33528757)

  • 21. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A; Janez A; Goricar K; Jensterle M
    BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study.
    Zavatta G; Vicennati V; Altieri P; Tucci L; Colombin G; Coscia K; Mosconi C; Balacchi C; Fanelli F; Malagrinò M; Magagnoli M; Golfieri R; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2023 Apr; 188(4):343-352. PubMed ID: 36952249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone and insulin resistance in menopausal patients with adrenal incidentalomas: The cause-effect relationship?
    Marina LV; Ivović M; Tančić-Gajić M; Arizanović Z; Raković D; Milin-Lazović J; Kendereški A; Micić D; Vujović S
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):541-548. PubMed ID: 29288564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.
    Belokovskaya R; Ravikumar A; Arumugam D; Izadmehr S; Goddard GM; Geer EB; Levine AC
    Endocr Pract; 2019 Aug; 25(8):846-853. PubMed ID: 31070948
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
    Araujo-Castro M; Pascual-Corrales E; Lamas C
    Ann Endocrinol (Paris); 2023 Apr; 84(2):272-284. PubMed ID: 36736771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
    Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
    Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
    Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?
    Morelli V; Ghielmetti A; Caldiroli A; Grassi S; Siri FM; Caletti E; Mucci F; Aresta C; Passeri E; Pugliese F; Di Giorgio A; Corbetta S; Scillitani A; Arosio M; Buoli M; Chiodini I
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e130-e139. PubMed ID: 33017843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life and fatigue in patients with adrenal incidentaloma.
    Kastelan D; Dzubur F; Dusek T; Poljicanin T; Crncevic-Orlic Z; Kraljevic I; Solak M; Bencevic T; Aganovic I; Knezevic N; Kastelan Z; Korsic M
    Endocrine; 2011 Aug; 40(1):84-9. PubMed ID: 21442381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension.
    Pappa T; Papanastasiou L; Kaltsas G; Markou A; Tsounas P; Androulakis I; Tsiavos V; Zografos G; Vamvakidis K; Samara C; Piaditis G
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E537-45. PubMed ID: 22319028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
    Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.